Ethical Considerations in Orphan Drug Approval and Use

The Orphan Drug Act aims to advance therapeutic options for rare disease patients, but orphan drugs typically undergo more limited premarket testing than non-orphan drugs, resulting in greater clinical uncertainty. The authors argue that the ethical principles of justice and beneficence necessitate enhanced informed consent procedures for patients receiving orphan drugs and increased investment in postmarket surveillance and confirmatory testing.